AstaPure Gets OK on Structure/Function Claims

KIBBUTZ KETURA, IsraelAlgatechnologies announced FDA had no questions regarding its submission of 12 potential structure/function claims to use in marketing of its AstaPure® brand natural astaxanthin. The claims relate to the healthy functioning of a number of systems, including cardiovascular health, neurological health and antioxidant balance.

Astaxanthin is one of the most researched bioactive ingredients, and AstaPure is a leading brand for purity and quality, said Efrat Kat, marketing and sales director, Algatechnologies. This important move will help us engender more market-share growth in the United States. The allowed use of the claims is a part of the companys global plan to invest in expanding regulatory approvals for its growing products line. Other countries in which the company has plans to increase its presence are South Korea, India and Australia.

Algatechnologies produces its astaxanthin using a patented closed, environmentally protected cultivation system. The AstaPure line includes a 10 percent astaxanthin oleoresin extracted using CO2 super critical extraction technology, 2.5 percent astaxanthin beadlets and 2 percent astaxanthin vegetarian beadlets, as well as cold-water-dispersible beadlets and 4 mg softgels.